A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer

Autor: Besse, B. *, Heist, R.S., Papadmitrakopoulou, V.A., Camidge, D.R., Beck, J.T., Schmid, P., Mulatero, C., Miller, N., Dimitrijevic, S., Urva, S., Pylvaenaeinen, I., Petrovic, K., Johnson, B.E.
Zdroj: In Annals of Oncology February 2014 25(2):505-511
Databáze: ScienceDirect